Dorsey & Whitney Trust CO LLC Boosts Holdings in Koninklijke Philips (NYSE:PHG)

Dorsey & Whitney Trust CO LLC lifted its stake in Koninklijke Philips (NYSE:PHG) by 3.9% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 11,401 shares of the technology company’s stock after purchasing an additional 427 shares during the quarter. Dorsey & Whitney Trust CO LLC’s holdings in Koninklijke Philips were worth $289,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors have also recently modified their holdings of the stock. FMR LLC increased its holdings in Koninklijke Philips by 0.6% in the 3rd quarter. FMR LLC now owns 6,138,708 shares of the technology company’s stock worth $200,859,000 after buying an additional 35,935 shares in the last quarter. Bank of Montreal Can increased its holdings in Koninklijke Philips by 2,883.5% in the 3rd quarter. Bank of Montreal Can now owns 982,199 shares of the technology company’s stock worth $32,157,000 after buying an additional 949,278 shares in the last quarter. IHT Wealth Management LLC bought a new stake in Koninklijke Philips in the 3rd quarter worth about $19,593,000. Raymond James Financial Inc. bought a new stake in Koninklijke Philips in the 4th quarter worth about $10,655,000. Finally, Bar Harbor Wealth Management increased its holdings in Koninklijke Philips by 2.1% in the 4th quarter. Bar Harbor Wealth Management now owns 308,157 shares of the technology company’s stock worth $7,803,000 after buying an additional 6,281 shares in the last quarter. Hedge funds and other institutional investors own 13.67% of the company’s stock.

Koninklijke Philips Trading Down 0.0 %

Koninklijke Philips stock opened at $26.75 on Wednesday. The business has a 50-day simple moving average of $26.57 and a two-hundred day simple moving average of $27.92. The company has a market cap of $25.15 billion, a P/E ratio of -31.85, a P/E/G ratio of 0.82 and a beta of 0.78. Koninklijke Philips has a 52-week low of $19.10 and a 52-week high of $32.91. The company has a quick ratio of 0.74, a current ratio of 1.23 and a debt-to-equity ratio of 0.59.

Koninklijke Philips (NYSE:PHG) last released its quarterly earnings results on Wednesday, February 19th. The technology company reported $0.54 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.55 by ($0.01). The firm had revenue of $5.38 billion for the quarter, compared to the consensus estimate of $5.10 billion. Koninklijke Philips had a negative net margin of 3.88% and a positive return on equity of 10.85%. Analysts predict that Koninklijke Philips will post 1.63 EPS for the current year.

Koninklijke Philips Cuts Dividend

The company also recently declared an annual dividend, which will be paid on Friday, June 6th. Shareholders of record on Tuesday, May 13th will be paid a dividend of $0.886 per share. The ex-dividend date is Tuesday, May 13th. This represents a dividend yield of 2.9%. Koninklijke Philips’s dividend payout ratio is currently -89.29%.

Analyst Upgrades and Downgrades

PHG has been the subject of several research analyst reports. StockNews.com upgraded Koninklijke Philips from a “hold” rating to a “buy” rating in a report on Saturday. UBS Group upgraded Koninklijke Philips from a “neutral” rating to a “buy” rating in a report on Thursday, February 20th. Finally, BNP Paribas upgraded Koninklijke Philips from a “neutral” rating to an “outperform” rating in a research note on Tuesday, February 25th. Two analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy”.

Koninklijke Philips Company Profile

Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease.